Mitral annular disjunction and its progression during childhood in Marfan syndrome

Tam T Doan1,2, Alejandra Iturralde Chavez1,2, Santiago O Valdes1,2

  • 1Division of Cardiology, Texas Children's Hospital, 6651 Main Street MC-E1920, Houston, TX 77030, USA.

Abstract

Insights

Mitral annular disjunction (MAD) is common in children with Marfan syndrome (MFS), affecting 60% of patients and associating with aortic root dilation. Echocardiography and cardiac magnetic resonance imaging (CMR) reliably detect MAD, which progresses with age but normalizes when indexed by height.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Medical Imaging

Background:

  • Data on mitral annular disjunction (MAD) in pediatric Marfan syndrome (MFS) are limited.
  • Understanding MAD's prevalence, progression, and diagnostic methods in MFS is crucial for early intervention.

Purpose of the Study:

  • To investigate the diagnostic yield of MAD using echocardiography and cardiac magnetic resonance imaging (CMR) in children with MFS.
  • To determine the prevalence and progression of MAD throughout childhood in MFS patients.

Main Methods:

  • Retrospective analysis of pediatric MFS patients (<21 years) diagnosed by 2010 Ghent criteria and FBN1 variant or ectopia lentis.
  • Two readers measured mitral valve (MV)-left ventricular (LV) myocardial separation (MAD) and MV prolapse (MVP) on initial and follow-up echocardiograms and CMRs.
  • Statistical analysis included agreement (Kappa, ICC) and longitudinal change (mixed-effects linear regression) evaluation.

Main Results:

  • MAD was detected in 60% of eligible MFS patients.
  • Echocardiography and CMR showed high agreement (Kappa=0.89) and reliability (ICC=0.91-0.97) for MAD detection.
  • MAD was associated with aortic root dilation and progressed by +0.18 mm/year, but remained constant when indexed by height.

Conclusions:

  • Mitral annular disjunction is a common finding in pediatric Marfan syndrome, frequently associated with aortic root dilation.
  • Echocardiography and CMR are reliable modalities for routine MAD assessment in pediatric MFS.
  • MAD progresses with age but normalizes when height-indexed, suggesting potential as a clinical outcome biomarker.